Highland Capital Management Fund Advisors, L.P. Precision Biosciences Inc Transaction History

Highland Capital Management Fund Advisors, L.P.

$846 Million
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2019 Feb 14, 2020	SELL	$6.32 - $19.66 $410,800 - $1.28 Million	-65,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$8.03 - $14.82 $521,949 - $963,300	65,000 New	65,000 $545,000

Others Institutions Holding DTIL

# of Institutions

Shares Held

2.56M

Call Options Held

Put Options Held

Oup Management Co., LLC

1.12M
Shares

$5.61 Million
0.86% of portfolio
Chi Advisors LLC New York, NY

607K
Shares

$3.03 Million
0.1% of portfolio
Jacob Asset Management Of New York LLC Hermosa Beach, CA

390K
Shares

$1.95 Million
0.19% of portfolio
Tekla Capital Management LLC

225K
Shares

$1.12 Million
0.0% of portfolio
Vericrest Private Wealth Newtown, PA

155K
Shares

$771,923
0.3% of portfolio

View Full List

About PRECISION BIOSCIENCES INC

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $553M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

More about DTIL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management Fund Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management Fund Advisors, L.P. with notifications on news.

Account